A multi-center phase i trial of ipilimumab in patients with myelodysplastic syndromes following hypomethylating agent failure
- Amer M. Zeidan
- , Hanna A. Knaus
- , Tara M. Robinson
- , Andrea M.H. Towlerton
- , Edus H. Warren
- , Joshua F. Zeidner
- , Amanda L. Blackford
- , Amy S. Duffield
- , David Rizzieri
- , Mark G. Frattini
- , Yair M. Levy
- , Mark A. Schroeder
- , Anna Ferguson
- , Katherine E. Sheldon
- , Amy E. DeZern
- , Ivana Gojo
- , Steven D. Gore
- , Howard Streicher
- , Leo Luznik
- , B. Douglas Smith
Research output: Contribution to journal › Article › peer-review
91
Link opens in a new tab
Scopus
citations